Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up - PubMed (original) (raw)

Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up

Silke Lassmann et al. Int J Colorectal Dis. 2006 Apr.

Abstract

Aim: Evaluation of thymidine phosphorylase (TP), dihydropyrimidine dehydrogenase (DPD), and thymidylate synthase (TS) mRNA levels in formalin-fixed, and paraffin-embedded tissues of patients with colorectal cancer and their prognostic and/or predictive value.

Materials and methods: Total RNA was isolated from microdissected, formalin-fixed, and paraffin-embedded tissues (controls and tumor) and subjected to quantitative RT-PCR (QRT-PCR) in the LightCycler system. Resulting mRNA levels correlated to tumor histology (n=102) and the clinical follow-up in patients treated by resection alone (n=40) and by resection plus adjuvant 5-FU-based chemotherapy (n=52).

Results: Correlation to histopathological parameters revealed a significant association between tumor stage and the TP mRNA level (T and N category and UICC) as well as the TP:DPD (T and N category and UICC) and TS:DPD (T category) ratio. In addition, tumor differentiation was correlated to the TS mRNA level and the TS:DPD ratio. Finally, the TS:DPD ratio was a prognostic marker for overall survival in patients receiving resection alone (p=0.032). Moreover, a high TP:DPD ratio (>8.1; p=0.002) and, marginally, low DPD (<8.2; p=0.05) mRNA levels significantly correlated to disease-free survival.

Conclusion: We present a novel, standardized approach for TP, DPD, and TS mRNA quantification in archival tissue specimens and applied this to a large series of primary colorectal tumors. Correlations to histopathological parameters and clinical follow-up revealed an association of TP, DPD and TS mRNA expression patterns with tumor stage and suggested new prognostic and predictive markers for patients with colorectal cancer.

PubMed Disclaimer

Similar articles

• Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
  Jakob C, Aust DE, Meyer W, Baretton GB, Schwabe W, Häusler P, Becker H, Liersch T. Jakob C, et al. J Pathol. 2004 Dec;204(5):562-8. doi: 10.1002/path.1663. J Pathol. 2004. PMID: 15538739
• Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
  Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C. Ciaparrone M, et al. Oncology. 2006;70(5):366-77. doi: 10.1159/000098110. Epub 2006 Dec 15. Oncology. 2006. PMID: 17179731
• Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
  Kinoshita M, Kodera Y, Hibi K, Nakayama G, Inoue T, Ohashi N, Ito Y, Koike M, Fujiwara M, Nakao A. Kinoshita M, et al. Anticancer Res. 2007 Mar-Apr;27(2):851-6. Anticancer Res. 2007. PMID: 17465211
• Determinants of prognosis and response to therapy in colorectal cancer.
  Iqbal S, Lenz HJ. Iqbal S, et al. Curr Oncol Rep. 2001 Mar;3(2):102-8. doi: 10.1007/s11912-001-0008-5. Curr Oncol Rep. 2001. PMID: 11177741 Review.
• Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.
  Banerjee D, Mayer-Kuckuk P, Capiaux G, Budak-Alpdogan T, Gorlick R, Bertino JR. Banerjee D, et al. Biochim Biophys Acta. 2002 Jul 18;1587(2-3):164-73. doi: 10.1016/s0925-4439(02)00079-0. Biochim Biophys Acta. 2002. PMID: 12084458 Review.

Cited by

• Clinical management of localized colon cancer with capecitabine.
  Quidde J, Arnold D, Stein A. Quidde J, et al. Clin Med Insights Oncol. 2012;6:363-73. doi: 10.4137/CMO.S8194. Epub 2012 Nov 5. Clin Med Insights Oncol. 2012. PMID: 23170068 Free PMC article.
• Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA in intrahepatic cholangiocarcinoma.
  Morine Y, Shimada M, Utsunomiya T, Imura S, Ikemoto T, Hanaka J, Kanamoto M, Kurita N, Miyake H. Morine Y, et al. Surg Today. 2012 Jan;42(2):135-40. doi: 10.1007/s00595-011-0054-z. Epub 2011 Dec 6. Surg Today. 2012. PMID: 22143355
• Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability.
  Donada M, Bonin S, Nardon E, De Pellegrin A, Decorti G, Stanta G. Donada M, et al. J Cancer Res Clin Oncol. 2011 Feb;137(2):201-10. doi: 10.1007/s00432-010-0872-1. Epub 2010 Apr 13. J Cancer Res Clin Oncol. 2011. PMID: 20387074
• The dual role of thymidine phosphorylase in cancer development and chemotherapy.
  Bronckaers A, Gago F, Balzarini J, Liekens S. Bronckaers A, et al. Med Res Rev. 2009 Nov;29(6):903-53. doi: 10.1002/med.20159. Med Res Rev. 2009. PMID: 19434693 Free PMC article. Review.

References

1. 1. Clin Cancer Res. 1999 Aug;5(8):2006-11 - PubMed
2. 1. J Pathol. 1995 Jun;176(2):183-90 - PubMed
3. 1. Cancer Res. 2001 Jul 15;61(14):5505-10 - PubMed
4. 1. Br J Cancer. 2001 Sep 14;85(6):827-30 - PubMed
5. 1. Br J Cancer. 1997;75(6):903-9 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Medical

  • MedlinePlus Health Information